1. Introduction

Risk assessment before Genetically Modified Organism (GMO) approval is a fundamental legal and scientific requirement designed to ensure that genetically modified plants, animals, microorganisms and other biological products do not create unacceptable risks to human health, animal health, biodiversity or the environment.

A Genetically Modified Organism is an organism whose genetic material has been altered through modern biotechnology techniques, such as recombinant DNA technology, gene insertion, gene deletion or genome editing.

Before a GMO is released commercially, cultivated, imported or introduced into the environment, regulatory authorities must evaluate its potential consequences.

The central principle is that GMO approval must be based on scientific evidence, precaution, transparency and regulatory accountability rather than commercial interests alone.

Risk assessment is different from risk management:

Risk assessment identifies and scientifically evaluates potential dangers.

Risk management determines what regulatory measures are necessary to control those dangers.

Risk communication ensures that scientific findings and regulatory decisions are communicated to affected communities and stakeholders.

2. Objectives of Pre-Approval GMO Risk Assessment

The principal objectives include:

Human health protection: Examining potential toxicity, allergenicity, nutritional changes and unintended health effects.

Environmental protection: Identifying risks to ecosystems, soil organisms, water systems and biodiversity.

Gene-flow prevention: Assessing whether modified genetic material could spread to conventional crops or wild relatives.

Resistance management: Evaluating the possibility of herbicide-resistant weeds and insect-resistant pests.

Biodiversity conservation: Examining possible effects on non-target organisms, pollinators and beneficial insects.

Food and feed safety: Determining whether GMO-derived products are safe for human and animal consumption.

Long-term monitoring: Identifying risks that may emerge after commercial approval.

Regulatory accountability: Ensuring that approval decisions are supported by reliable evidence and can be reviewed or challenged.

3. Legal Framework Governing GMO Risk Assessment

A. International legal framework

1. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol is one of the most important international instruments governing the safe handling, transfer and use of living modified organisms (LMOs).

Its principal provisions include:

Article 1: Establishes the objective of protecting biodiversity while considering risks to human health.

Article 10: Establishes procedures for decisions concerning imports of living modified organisms.

Article 15: Provides the framework for risk assessment.

Annex III: Establishes the methodology for conducting risk assessments.

Article 16: Requires appropriate risk-management measures.

Article 17: Addresses unintentional transboundary movements.

Annex III requires scientific evaluation of potential adverse effects, including the likelihood and consequences of those effects.

2. Convention on Biological Diversity, 1992

The Convention on Biological Diversity establishes the broader international obligation to conserve biodiversity and promote the safe use of biotechnology.

Article 8(g) specifically addresses the regulation, management or control of risks associated with living modified organisms resulting from biotechnology.

3. WTO Agreement on Sanitary and Phytosanitary Measures (SPS Agreement)

The SPS Agreement is relevant where GMO-related measures concern food safety, animal health or plant health.

Important provisions include:

Article 2: Scientific justification for sanitary and phytosanitary measures.

Article 3: International standards.

Article 5: Risk assessment and appropriate protection levels.

Article 5.7: Provisional measures where relevant scientific evidence is insufficient.

These provisions seek to balance public-health protection with international trade obligations.

B. Indian legal framework

India regulates GMO research, testing, environmental release and commercial use through several legal instruments.

1. Environment (Protection) Act, 1986

This is the principal enabling legislation for regulating activities involving genetically engineered organisms.

2. Environment (Protection) Rules, 1986

Rules 7–11 and the associated regulatory framework govern hazardous microorganisms and genetically engineered organisms.

3. 1989 Rules on Genetically Engineered Organisms

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells establish different regulatory bodies, including:

Recombinant DNA Advisory Committee (RDAC).

Institutional Biosafety Committee (IBSC).

Review Committee on Genetic Manipulation (RCGM).

Genetic Engineering Appraisal Committee (GEAC).

State Biotechnology Coordination Committee (SBCC).

District Level Committee (DLC).

GEAC plays a central role in evaluating proposals involving environmental release of GMOs.

4. Food Safety and Standards Act, 2006

Where GMO products are intended for human consumption, food safety requirements, including applicable approval, labelling and safety standards, become relevant.

C. Australian legal framework

Australia provides a statutory model for pre-approval GMO risk assessment under the Gene Technology Act 2000 (Cth).

The Office of the Gene Technology Regulator (OGTR) administers the licensing framework.

Important statutory provisions include:

The statutory framework therefore makes risk assessment a prerequisite to licensing rather than merely a voluntary scientific exercise.

Federal Register of Legislation+1

4. Essential Components of Risk Assessment Before GMO Approval

4.1 Molecular characterisation

The first stage examines the genetic modification itself.

Regulators investigate:

The inserted genetic sequence.

The source of the inserted gene.

The location of genetic insertion.

Whether genetic material has been unintentionally altered.

Whether the inserted gene is stable across generations.

Whether unexpected proteins are produced.

For example, if a crop has been genetically modified to resist insects, regulators must examine the introduced gene and the protein it produces.

4.2 Toxicity assessment

Toxicity assessment determines whether the GMO or its products could cause harmful effects in humans or animals.

Scientific investigations may examine:

Acute toxicity.

Sub-chronic toxicity.

Chronic toxicity, where scientifically relevant.

Metabolic effects.

Organ toxicity.

Potential unintended biochemical changes.

A regulator should not assume that a GMO is dangerous merely because it is genetically modified. Equally, it should not assume that it is safe simply because its conventional counterpart is widely consumed.

4.3 Allergenicity assessment

A newly introduced protein may potentially trigger allergic reactions.

Assessment may include:

Comparison with known allergens.

Protein stability.

Digestibility.

Amino-acid sequence analysis.

Relevant immunological evidence.

This is particularly important for GM crops used as food.

4.4 Environmental risk assessment

Environmental risk assessment evaluates the possible consequences of releasing the GMO into its receiving environment.

Important considerations include:

Effects on soil microorganisms.

Effects on pollinators.

Effects on birds and beneficial insects.

Changes in biodiversity.

Effects on non-target species.

Potential invasiveness.

Changes in ecological relationships.

Effects on agricultural ecosystems.

The assessment should consider the specific geographical region where the GMO is intended to be cultivated.

4.5 Gene-flow assessment

Gene flow occurs when genetic material moves from a genetically modified organism to another organism.

For example, pollen from a GM mustard crop may potentially fertilise compatible non-GM mustard plants.

The regulator should examine:

Pollination mechanisms.

Distance between cultivated crops.

Presence of compatible wild relatives.

Seed dispersal.

Cross-pollination probability.

Possibility of genetic contamination.

4.6 Resistance development

Some GM crops are designed to resist particular insects or tolerate particular herbicides.

However, prolonged use may encourage the development of resistant insects or weeds.

Regulators should therefore evaluate:

Resistance development probability.

Evolutionary pressure.

Refuge requirements.

Crop rotation.

Integrated pest management.

Long-term effectiveness of resistance-management measures.

4.7 Socio-economic considerations

Although socio-economic assessment is distinct from scientific biosafety assessment, it may be relevant to the broader approval decision.

Considerations can include:

Effects on small farmers.

Seed-market concentration.

Dependence on patented seeds.

Consumer choice.

Coexistence with organic agriculture.

Effects on traditional crop varieties.

Article 26 of the Cartagena Protocol expressly recognises socio-economic considerations in certain decisions concerning living modified organisms.

4.8 Long-term monitoring

Approval should not necessarily end regulatory scrutiny.

Where appropriate, regulators may require:

Post-release environmental monitoring.

Food-safety surveillance.

Resistance monitoring.

Reporting of unexpected adverse effects.

Periodic review of licence conditions.

Corrective action where new evidence emerges.

5. Important Judicial Decisions and Case Laws

The following decisions establish important principles concerning scientific assessment, environmental precaution, GMO approval and regulatory accountability.

Case 1. Gene Campaign v. Union of India (2024) 2024 INSC 545

Most directly relevant Indian case

Court: Supreme Court of India
Decision: 23 July 2024

Facts:

The case concerned the approval granted by the Genetic Engineering Appraisal Committee (GEAC) for environmental release of genetically modified mustard hybrid DMH-11.

The petitioners challenged the approval on grounds including:

Insufficient environmental risk assessment.

Potential damage to biodiversity.

Possible effects on honeybees and pollinators.

Herbicide-tolerance concerns.

Failure to adequately consider scientific uncertainties.

Insufficient public and stakeholder consultation.

Judgment:

The two judges delivered separate opinions and disagreed on the validity of the approval.

Justice B.V. Nagarathna:

Considered the approval process legally defective.

Emphasised the need to assess effects on human, animal and plant health.

Highlighted shortcomings concerning biosafety, soil health, microbiology and socio-economic impacts.

Considered the precautionary principle essential.

Favoured invalidating the environmental-release approval.

Justice Sanjay Karol:

Considered the conditional approval legally sustainable.

Emphasised the regulatory authority's scientific and policy-making responsibilities.

Supported continued field testing subject to safeguards.

Called for independent studies and appropriate environmental monitoring.

Common directions:

The Court agreed that GMO regulatory decisions are subject to judicial review. It also directed the Union Government to formulate a national policy on GM crops through stakeholder consultation and address expert conflicts of interest.

Legal significance:

This is a particularly important Indian authority for the proposition that GMO approval requires scientifically supported risk assessment, procedural fairness, transparency and accountable expert decision-making.

Importantly, this was a split verdict. The disagreement over the validity of the DMH-11 approval was referred for consideration by a larger Bench; it should not be described as a unanimous judgment quashing that approval.

India+2

Case 2. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647

Court: Supreme Court of India

Facts:

The case concerned environmental pollution caused by untreated industrial effluents discharged by tanneries in Tamil Nadu.

Judgment:

The Supreme Court recognised the precautionary principle and the polluter-pays principle as essential components of Indian environmental law.

Principles established:

Environmental protection must be preventive.

Scientific uncertainty does not automatically justify environmental inaction.

Authorities must take reasonable measures to prevent serious environmental harm.

Economic development must be balanced against environmental protection.

Relevance to GMO approval:

Where a GMO may cause irreversible damage to biodiversity, regulatory authorities should investigate potential risks before permitting environmental release.

The principle supports preventive biosafety assessment rather than waiting for environmental damage to occur.

Case 3. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718

Court: Supreme Court of India

Facts:

The dispute involved environmental clearance for an industry proposed near a drinking-water reservoir.

Judgment:

The Supreme Court discussed the difficulties of environmental decision-making where scientific evidence is uncertain or technically complex.

It emphasised the importance of scientific expertise and precaution in environmental governance.

Legal principles:

Scientific uncertainty requires careful regulatory examination.

Expert evidence should inform environmental decisions.

Decision-makers must consider potential environmental consequences.

Precautionary measures may be justified before harm is conclusively established.

Relevance to GMO approval:

GMO assessment often involves complex genetic, ecological and toxicological evidence. Regulators should therefore rely on competent independent scientific experts and properly documented research.

Case 4. Karl Heinz Bablok v. Freistaat Bayern (Case C-442/09, 2011)

Court: Court of Justice of the European Union

Facts:

A beekeeper challenged the presence of pollen derived from genetically modified MON 810 maize in honey.

The dispute concerned whether honey containing GMO-derived pollen could be marketed without the required authorisation.

Judgment:

The Court held that honey containing pollen derived from a GMO constituted food produced from GMOs and required prior authorisation under the applicable EU food legislation.

Legal significance:

The decision demonstrates that GMO-related risk and regulatory obligations may extend beyond the original cultivated crop.

Relevance to pre-approval assessment:

Regulators should consider:

Movement of pollen.

Effects on beekeeping.

Cross-contamination.

Food-chain exposure.

Consequences for neighbouring agricultural activities.

curia

Case 5. Confédération paysanne and Others v. Premier ministre and Ministre de l'Agriculture (Case C-528/16, 2018)

Court: Court of Justice of the European Union

Facts:

The dispute concerned organisms obtained through techniques of mutagenesis and whether they fell within EU GMO legislation.

Judgment:

The Court held that organisms obtained through techniques of mutagenesis are, in principle, GMOs within the meaning of the relevant EU legislation, subject to the applicable statutory exemptions.

Legal significance:

The judgment demonstrates that the regulatory classification of genetically modified organisms depends on the applicable legal definitions and the techniques employed.

Relevance to risk assessment:

Regulators must carefully identify the genetic modification technique before deciding which statutory approval and risk-assessment requirements apply.

Case 6. Giorgio Fidenato and Others (Case C-111/16, 2017)

Court: Court of Justice of the European Union

Facts:

The dispute involved Italian restrictions on the cultivation of genetically modified MON 810 maize.

Judgment:

The Court examined the conditions under which emergency protective measures could be adopted under EU GMO and food-safety legislation.

It held that the relevant emergency provisions require evidence establishing the statutory threshold of a serious risk; the precautionary principle alone does not dispense with those requirements.

Relevance to GMO approval:

Precaution is important, but regulatory decisions must also satisfy the applicable legal and evidentiary requirements. Risk assessment must be properly connected to the protective measures imposed.

EUR-Lex

6. The Precautionary Principle in GMO Approval

The precautionary principle is central to pre-approval risk assessment.

It means that where there is a credible possibility of serious or irreversible environmental damage, lack of complete scientific certainty should not automatically prevent protective regulatory action.

For example, suppose a genetically modified crop is designed to tolerate a particular herbicide.

Before approval, the authority should examine:

Whether the crop can cross-pollinate with related plants.

Whether herbicide use could encourage resistant weeds.

Whether beneficial organisms could be affected.

Whether biodiversity could be affected over successive growing seasons.

Whether proposed containment measures are effective.

However, precaution does not mean that every GMO must automatically be prohibited.

It requires proportionate, scientifically reasoned and legally defensible measures.

The Cartagena Protocol expressly states that a lack of scientific knowledge or consensus should not automatically be interpreted as an absence of risk or an acceptable level of risk.

Convention on Biological Diversity+1

7. Legal Responsibilities of Regulatory Authorities

Regulatory authorities have several important responsibilities before approving a GMO.

A regulator may face legal challenge where it:

Ignores significant scientific evidence.

Relies on incomplete or misleading studies.

Fails to consider foreseeable environmental consequences.

Allows conflicts of interest to compromise expert evaluation.

Ignores mandatory consultation procedures.

Grants approval without adequate reasons.

8. Legal Consequences of Inadequate GMO Risk Assessment

Failure to conduct a legally adequate risk assessment may result in several consequences.

A. Cancellation or suspension of approval

A court may invalidate an approval where the decision violates statutory requirements, ignores material evidence or is procedurally unlawful.

B. Environmental compensation

Where GMO-related activities cause environmental damage, applicable environmental liability and compensation principles may become relevant.

C. Restrictions on commercial cultivation

Authorities may impose restrictions on cultivation, importation, transportation or environmental release.

D. Mandatory additional testing

Regulators may require additional toxicity studies, environmental studies or controlled field trials before reconsidering approval.

E. Judicial review

Courts may examine whether the regulatory authority acted within its legal powers, considered relevant scientific evidence and complied with procedural requirements.

9. Comparative Analysis: India, Australia and the European Union

10. Important International Legal Principles

Five principles are particularly important when assessing whether a GMO should be approved.

Scientific soundness: Decisions must rely on scientifically credible evidence.

Case-by-case assessment: Each GMO must be assessed according to its characteristics, intended use and receiving environment.

Comparative assessment: The GMO should be evaluated against an appropriate non-modified comparator.

Precaution: Serious potential harm must not be ignored merely because scientific uncertainty remains.

Proportionality: Regulatory restrictions should be appropriate to the risks identified.

The Cartagena Protocol's Annex III provides the central international methodology for these principles.

Convention on Biological Diversity+2

11. Critical Legal Issues and Challenges

Despite the existence of international and national biosafety frameworks, several challenges remain.

1. Scientific uncertainty

Long-term ecological effects may be difficult to predict, particularly where modified organisms interact with complex ecosystems.

2. Conflicts of interest

Researchers, biotechnology companies and regulatory experts may have competing institutional or financial interests. Disclosure and independent evaluation are important safeguards.

3. Confidential business information

Companies may seek confidentiality for commercially sensitive genetic information. However, confidentiality should not undermine meaningful public scrutiny of biosafety findings.

4. Limited long-term evidence

Short-term experimental results may not establish the long-term safety of environmental release.

5. Regulatory fragmentation

Different authorities may regulate environmental release, food safety, agriculture, importation and labelling. Coordination is essential.

6. Transboundary environmental consequences

Pollen, seeds and other biological material may cross national borders. This creates difficult questions concerning liability, monitoring and regulatory cooperation.

12. Recommendations for Strengthening GMO Approval Laws

The following reforms could improve pre-approval biosafety regulation:

Establish independent scientific assessment panels.

Require comprehensive molecular and environmental risk studies.

Introduce stronger conflict-of-interest disclosure requirements.

Publish non-confidential biosafety assessment reports.

Improve consultation with farmers and affected communities.

Require location-specific environmental assessments.

Establish scientifically justified long-term monitoring requirements.

Develop emergency response and containment mechanisms.

Strengthen cross-border biosafety cooperation.

Provide periodic reassessment where new scientific evidence emerges.

13. Conclusion

Risk assessment before GMO approval is an essential component of modern biotechnology law and environmental governance.

The Cartagena Protocol, India's Environment (Protection) Act and 1989 GMO Rules, Australia's Gene Technology Act 2000 and European GMO legislation establish regulatory mechanisms for evaluating the safety of genetically modified organisms.

The most important Indian judicial authority is Gene Campaign v. Union of India (2024), which demonstrates the importance of scientific evaluation, transparency, stakeholder participation, precaution and judicial review in GMO approval decisions.

The fundamental legal proposition is that no GMO should receive regulatory approval without an adequate, transparent and scientifically defensible assessment of its potential risks to human health, animal health and the environment.

14. Important References for Further Legal Research

Cartagena Protocol – Annex III: Risk Assessment.

Australian Gene Technology Act 2000.

Gene Campaign v. Union of India – Supreme Court judgment, 2024.

Bablok v. Freistaat Bayern – CJEU judgment.

Fidenato and Others – CJEU judgment.

Research note: The 2024 Gene Campaign decision is especially important because the two judges disagreed on the validity of the DMH-11 approval. Their common directions and the separate opinions must be distinguished when using this case in academic writing.

I can also prepare this topic as an 800–1,000-word legal research article with Indian case citations, Australian legislation and comparative international jurisprudence.